<- Go Home

Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA operates as a subsidiary of Soparfin SCA.

Market Cap

EUR 833.3M

Volume

4.9K

Cash and Equivalents

EUR 221.1M

EBITDA

EUR 103.4M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 308.0M

Profit Margin

58.58%

52 Week High

EUR 91.50

52 Week Low

EUR 67.20

Dividend

1.30%

Price / Book Value

1.41

Price / Earnings

14.53

Price / Tangible Book Value

2.13

Enterprise Value

EUR 627.6M

Enterprise Value / EBITDA

5.73

Operating Income

EUR 79.8M

Return on Equity

9.82%

Return on Assets

6.62

Cash and Short Term Investments

EUR 221.1M

Debt

EUR 15.3M

Equity

EUR 591.4M

Revenue

EUR 525.7M

Unlevered FCF

EUR 49.5M

Sector

Pharmaceuticals

Category

N/A

Company Stock Pitches